| HERBERT PHARMACY LIMITED |
| Notes to the Accounts |
| for the year ended 31 December 2025 |
|
| 1 |
Accounting policies |
|
|
Basis of preparation |
|
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard). |
|
|
Intangible fixed assets |
|
Intangible fixed assets are measured at cost less accumulative amortisation and any accumulative impairment losses. |
|
|
Tangible fixed assets |
|
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows: |
|
|
Plant & machinery |
15% reducing balance |
|
Motor vehicles |
15% reducing balance |
|
|
Stocks |
|
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first in first out method. The carrying amount of stock sold is recognised as an expense in the period in which the related revenue is recognised. |
|
|
Debtors |
|
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts. |
|
|
Creditors |
|
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method. |
|
| 2 |
Employees |
2025 |
|
2024 |
| Number |
Number |
|
|
Average number of persons employed by the company |
15 |
|
14 |
|
|
|
|
|
|
|
|
|
|
| 3 |
Intangible fixed assets |
£ |
|
Goodwill: |
|
|
Cost |
|
At 1 January 2025 |
963,014 |
|
At 31 December 2025 |
963,014 |
|
|
|
|
|
|
|
|
|
|
Amortisation |
|
At 31 December 2025 |
- |
|
|
|
|
|
|
|
|
|
|
Net book value |
|
At 31 December 2025 |
963,014 |
|
At 31 December 2024 |
963,014 |
|
|
|
|
|
|
|
|
|
|
Goodwill is being written off in equal annual instalments over its estimated economic life of 5 years. |
|
|
| 4 |
Tangible fixed assets |
|
|
|
|
Plant & machinery |
|
Motor vehicles |
|
Total |
| £ |
£ |
£ |
|
Cost |
|
At 1 January 2025 |
151,008 |
|
16,280 |
|
167,288 |
|
At 31 December 2025 |
151,008 |
|
16,280 |
|
167,288 |
|
|
|
|
|
|
|
|
|
|
Depreciation |
|
At 1 January 2025 |
145,592 |
|
8,991 |
|
154,583 |
|
Charge for the year |
812 |
|
1,093 |
|
1,905 |
|
At 31 December 2025 |
146,404 |
|
10,084 |
|
156,488 |
|
|
|
|
|
|
|
|
|
|
Net book value |
|
At 31 December 2025 |
4,604 |
|
6,196 |
|
10,800 |
|
At 31 December 2024 |
5,416 |
|
7,289 |
|
12,705 |
|
|
| 5 |
Debtors |
2025 |
|
2024 |
| £ |
£ |
|
|
Trade debtors |
64,797 |
|
122,248 |
|
VAT Receivable |
20,764 |
|
42,236 |
|
|
|
|
|
|
85,561 |
|
164,484 |
|
|
|
|
|
|
|
|
|
|
| 6 |
Creditors: amounts falling due within one year |
2025 |
|
2024 |
| £ |
£ |
|
|
Director's loan account |
- |
|
2,273 |
|
Trade creditors |
102,599 |
|
124,829 |
|
Wages |
1,226 |
|
65 |
|
Corporation tax |
75,817 |
|
76,318 |
|
HMRC Paye |
1,058 |
|
1,226 |
|
Pension |
256 |
|
- |
|
|
|
|
|
|
180,956 |
|
204,711 |
|
|
|
|
|
|
|
|
|
|
| 7 |
Other information |
|
|
HERBERT PHARMACY LIMITED is a private company limited by shares and incorporated in England. Its registered office is: |
|
36 - 38 Herbert Road |
|
Plumstead |
|
London |
|
England |
|
SE18 3SH |